These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22471583)

  • 1. Clinical utility of noninvasive fetal trisomy (NIFTY) test--early experience.
    Lau TK; Chan MK; Lo PS; Chan HY; Chan WS; Koo TY; Ng HY; Pooh RK
    J Matern Fetal Neonatal Med; 2012 Oct; 25(10):1856-9. PubMed ID: 22471583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non-invasive fetal trisomy (NIFTY) test in prenatal diagnosis].
    Łaczmańska I; Stembalska A
    Ginekol Pol; 2014 Apr; 85(4):300-3. PubMed ID: 24834709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-invasive prenatal diagnosis of the most common aneuploidies with cell-free fetal DNA in maternal serum--preliminary results].
    Bijok J; Gorzelnik K; Massalska D; Ilnicka A; Pawłowska B; Zimowski JG; Kucińska-Chahwan A; Jakiel G; Roszkowski T
    Ginekol Pol; 2014 Mar; 85(3):208-13. PubMed ID: 24783433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13.
    Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
    Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population.
    Nicolaides KH; Syngelaki A; Ashoor G; Birdir C; Touzet G
    Am J Obstet Gynecol; 2012 Nov; 207(5):374.e1-6. PubMed ID: 23107079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomies 21, 18 and 13 by cell-free DNA analysis of maternal blood at 10-11 weeks' gestation and the combined test at 11-13 weeks.
    Quezada MS; Gil MM; Francisco C; Oròsz G; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Jan; 45(1):36-41. PubMed ID: 25251385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.
    Jiang F; Ren J; Chen F; Zhou Y; Xie J; Dan S; Su Y; Xie J; Yin B; Su W; Zhang H; Wang W; Chai X; Lin L; Guo H; Li Q; Li P; Yuan Y; Pan X; Li Y; Liu L; Chen H; Xuan Z; Chen S; Zhang C; Zhang H; Tian Z; Zhang Z; Jiang H; Zhao L; Zheng W; Li S; Li Y; Wang J; Wang J; Zhang X
    BMC Med Genomics; 2012 Dec; 5():57. PubMed ID: 23198897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors.
    Dan S; Wang W; Ren J; Li Y; Hu H; Xu Z; Lau TK; Xie J; Zhao W; Huang H; Xie J; Sun L; Zhang X; Wang W; Liao S; Qiang R; Cao J; Zhang Q; Zhou Y; Zhu H; Zhong M; Guo Y; Lin L; Gao Z; Yao H; Zhang H; Zhao L; Jiang F; Chen F; Jiang H; Li S; Li Y; Wang J; Wang J; Duan T; Su Y; Zhang X
    Prenat Diagn; 2012 Dec; 32(13):1225-32. PubMed ID: 23138752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.
    Yao H; Jiang F; Hu H; Gao Y; Zhu Z; Zhang H; Wang Y; Guo Y; Liu L; Yuan Y; Zhou L; Wang J; Du B; Qu N; Zhang R; Dong Y; Xu H; Chen F; Jiang H; Liu Y; Zhang L; Tian Z; Liu Q; Zhang C; Pan X; Yang S; Zhao L; Wang W; Liang Z
    Ultrasound Obstet Gynecol; 2014 Jul; 44(1):17-24. PubMed ID: 24616044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
    Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on "technical concerns on the clinical validation of the NIFTY test".
    Patsalis PC; Christopoulou G; Velissariou V
    Prenat Diagn; 2013 Dec; 33(13):1308-9. PubMed ID: 23619941
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
    Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation.
    Kagan KO; Cicero S; Staboulidou I; Wright D; Nicolaides KH
    Ultrasound Obstet Gynecol; 2009 Mar; 33(3):259-64. PubMed ID: 19248005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.
    Porreco RP; Garite TJ; Maurel K; Marusiak B; ; Ehrich M; van den Boom D; Deciu C; Bombard A
    Am J Obstet Gynecol; 2014 Oct; 211(4):365.e1-12. PubMed ID: 24657131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
    Fairbrother G; Johnson S; Musci TJ; Song K
    Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.